What is the Projected CAGR value of the Xerostomia Therapeutics Market ?
Xerostomia Therapeutics Market is expected to grow at a CAGR of 3.8% during the forecast period 2024-2031.
Who are the key players in Xerostomia Therapeutics Market ?
Major players are GlaxoSmithKline, Church & Dwight Co., Inc., Colgate-Palmolive Company, Acacia Pharma Group plc, Hikma Pharmaceuticals plc, Lupin Ltd., Parnell Pharmaceuticals Inc., Pendopharm, Virginia Head and Neck Therapeutics, Inc., Pfizer Inc. and Sun Pharmaceutical Industries Ltd.